Q: I was sick for months with debilitating pain, extreme weight loss, fatigue and loss of appetite. I was diagnosed with C. diff related to an abdominal surgery. I’m being treated with antibiotics, ...

Dear Doctors: I was sick for months with debilitating pain, extreme weight loss, fatigue and loss of appetite. I was diagnosed with C. diff related to an abdominal surgery. I’m being treated with ...

SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile (C. diff) for up to 2 months with no major safety signals, according to a ...

Vowst is a prescription drug that’s used in adults to help prevent Clostridioides difficile (C. diff) infection from coming back after it has been treated. Vowst comes as an oral capsule. Vowst ...

Am J Health Syst Pharm. 2012;69(11):933-943. Based on current clinical trials reporting fewer recurrences among patients treated with fidaxomicin in which the non-NAP1/BI/027 strains were isolated, ...

Vowst (fecal microbiota spores, live-brpk) is a brand-name oral capsule that’s prescribed to help prevent Clostridioides difficile (C. diff) infection returning after antibiotic treatment in certain ...

A 70-year-old woman with a history of Clostridium difficile infection returned to the clinic with abdominal pain and diarrhea. Three stool samples were negative for C. difficile and WBCs. Would you ...

At the end of 2010, Ellis Hospital noticed a troubling spike in Clostridium difficile infections. Clostridium difficile, or C-diff, is a common cause of diarrhea acquired in healthcare settings; it ...

Vowst (fecal microbiota spores, live-brpk) can cause side effects that range from mild to serious. More common side effects include tiredness and constipation. If side effects from Vowst become ...

The Emerging Infections Program used C. diff infections at 10 U.S. sites to estimate the national burden of C. diff through infection rates, recurrences, hospitalizations and hospital deaths from 2011 ...

Five insights from the report, written by Clayton Dalton, MD, a resident physician at Boston-based Massachusetts General Hospital: 1. In addition to antibiotic use being a risk factor for C. diff, ...

Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed. Conclusion ...